Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
Clinical trial NCT04034173 · UNKNOWN
Trial details
- NCT number
- NCT04034173
- Sponsor
- Ludwig-Maximilians - University of Munich
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2024-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.